Trypsin-chymotrypsin inhibitors from Vigna mungo seeds

Protein and Peptide Letters

Volumn 16, Issue 3, 2009, Pages 277-284

  Cheung, Allen H K ^a   Wong, Jack H ^a   Ng, T B ^a  

^a Chinese University of Hong Kong   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMOTRYPSIN; REVERSE TRANSCRIPTASE, HUMAN IMMUNODEFICIENCY VIRUS 1; RNA DIRECTED DNA POLYMERASE; TRYPSIN; TRYPSIN INHIBITOR; VEGETABLE PROTEIN;

ANIMAL; ARTICLE; CELL PROLIFERATION; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; LEGUME; METABOLISM; PLANT SEED; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CHYMOTRYPSIN; FABACEAE; HIV REVERSE TRANSCRIPTASE; HUMANS; PLANT PROTEINS; SEEDS; TRYPSIN; TRYPSIN INHIBITORS;

BOTRYOTINIA FUCKELIANA; FUSARIUM; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MYCOSPHAERELLA ARACHIDICOLA; VIGNA MUNGO;

EID: 63449097272     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986609787601714     Document Type: Article

References (70)

1. Chou, K, C.; Tomasselli, A, G,; Heinrikson, R. L. Prediction of the tertiary structure of a caspase-9/inhibitor complex, FEBS Lett., 2000, 470, 249-256,
2. Chou, K. C.; Jones, D.; Heinrikson, R. L. Prediction of the tertiary structure and substrate binding site of caspase-8. FEBS Lett., 1997, 419, 49-54.
3. Chou, K. C. Review: Structural bioinformatics and its impact to biomedical science. Curr. Med. Chem., 2004, 11, 2105-2134,
4. Chou, K. C.; Howe, W. J, Prediction of the tertiary structure of the beta-secretase zymogen, Biochem. Biophys. Res. Commun., 2002, 292, 702-708.
5. Hong, L.; Koelsch, G.; Lin, X.; Wu, S.; Terzyan, S.; Ghosh, A. K.; Zhang, X. C.; Tang, J. Structure of the protease domain of memapsin 2 -secretase) complexed with inhibitor. Science, 2000, 290, 150-153.
6. Chou, K. C. Insights from modelling the tertiary structure of BACE2. J. Proteome Res., 2004, 3, 1069-1072.
7. Chou, K. C. Modeling the tertiary structure of human cathepsin-E. Biochem. Biophys. Res. Commun, 2005, 331, 56-60,
8. Chou, K. C. A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins. J. Biol. Chem., 1993, 268, 16938-16948.
9. Sirois, S.: Sing, T.; Chou, K. C. Review: HIV-1 gp120 V3 loop for structure-based drag design. Curr. Protein Pept. Sci., 2005, 6, 413-422.
10. Chou, K, C. Review: Prediction of HIV protease cleavage sites in proteins. Anal. BioChem., 1996, 233, 1-14.
11. Liang, G. Z. : Li, S. Z. A new sequence representation (FASGAI) as applied in better specificity elucidation for human immunodeficiency virus type 1 protease. Biopolymers, 2007, 88(3), 401-12.
12. Sirois, S.; Tsoukas, C. M.; Chou, K. C.; Wei.; Boucher, C.; Hatza-kis, G. E. Selection of molecular descriptors with artificial intelligence for the understanding of HIV-1 protease peptidomimetic inhibitors-activity. Med. Chem.,2005, 1, 173-184.
13. Chou, K. C.; Wei, D. Q.; Zhong, W. Z. Binding mechanism of Coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochem. Biophys. Res. Comm., 2003, 308, 148-151.
14. Chou, K. C.; Wei, D. Q.; Du, Q. S.; Sirois, S.; Zhong, W. Z. Review: Progress in computational approach to drug development against SARS, Curr. Med. Chem., 2006, 13, 3263-3270.
15. Yang, H.; Ding, Y.; Liu, Y,; Lou, Z.; Zhou, Z.; Sun, L.; Mo, L.; Ye, S.; Pang, H.; Gao, G. F.; Anand, K.; Bartlam, M.; Hilgenfeld, R.; Rao, Z. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc. Natl. Acad. Sci. USA, 2003, 100, 13190-13195.
16. Anand, K.; Ziebuhr, J.; Wadhwani, P.; Mesters, J. R,; Hilgenfeld, R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science, 2003, 300, 1763-1767.
17. Du, Q. S.: Sun, H.; Chou, K. C. Inhibitor design for SARS Coronavirus main protease based on "distorted key theory". Med. Chem., 2007, 3, 1-6.
18. Wei, D. Q.; Zhang, R.; Du, Q. S.; Gao, W. N.; Li, Y.; Gao, H.; Wang, S. Q.; Zhang, X.; Li, A. X.; Sirois, S.; Chou, K. C. Anti-SARS drug screening by molecular docking. Amino Acids, 2006, 37, 73-80.
19. Zhang, R.; Wei, D. Q.; Du, Q. S.; Chou, K. C. Molecular modeling studies of peptide drug candidates against SARS. Med. Chem., 2006, 2, 309-314.
20. Du, Q. S.; Wang, S. Q.; Wei, D. Q.; Zhu, Y.; Guo, H.; Sirois, S.; Chou, K. C. Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of octapeptide. Peptides, 2004, 25, 1857-1864.
21. Sirois, S.; Wei, D. Q.; Du, Q. S.; Chou, K. C. Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points. J. Chem. Inf. Comput. Sci., 2004, 44, 1111-1122.
22. Du, Q. S.; Wang, S.; Wei, D. Q.; Sirois, S.; Chou, K. C. Molecular modelling and chemical modification for finding peptide inhibitor against SARS CoV Mpro. Anal. BioChem., 2005, 337, 262-270.
23. Du, Q. S.; Wang, S. Q.; Jiang, Z. Q.; Gao, W. N.; Li, Y. D.; Wei, D. Q.; Chou, K. C. Application of bioinformatics in search for cleavable peptides of SARS-CoV Mpro and chemical modification of octapeptides. Med. Chem., 2005, 1, 09-213.
24. Birk, Y. The Bowman-Birk inhibitor, trypsin- and chymotrypsininhibitor from soybeans, J. Pept. Protein Res. 1985, 25, 113-131.
25. Bosterling, B.; Quast, U. Soybean trypsin inhibitor (Kunitz) is doubleheaded. Kinetics of the interaction of alpha-chymotrypsin with each side. Biochim. Biophys. Acta, 1981, 657, 58-72.
26. Hara, S.; Makino, J.; Ikenaka, T. Amino acid sequences and disulfide bridges of serine proteinase inhibitors from bitter gourd (Momordica charantia LINN.) seeds. J. Biochem. (Tokyo), 1989, 105, 88-91.
27. Favel, A.; Mattras, H.; Coletti-Previero, M.A.; Zwilling, R.; Robinson, E.A.; Castro, B. Protease inhibitors from Ecballium elaterium seeds. Int. J. Pept. Protein Res., 1989, 33, 202-208.
28. Lee, CF.; Lin, J.Y. Amino acid sequences of trypsin inhibitors from the melon Cucumis melo. J. Biochem. (Tokyo), 1995, 118, 18-22.
29. Soares-Costa, A.; Beltramini, L.M.; Thiemann, O.H.; Henrique-Silva, F. A sugarcane cystatin: recombinant expression, purification, and antifungal activity, Biochem. Biophys. Res. Commun., 2002, 296, 1194-1199.
30. Cai, D.; Thurau, T.; Tian, Y.; Lange, T.; Yeh, K.W.; Jung, C. Spo-ramin-mediated resistance to beet cyst nematodes (Heterodera schachtii Schm.) is dependent on trypsin inhibitory activity in sugar beet (Beta vulgaris L.) hairy roots. Plant Mol. Biol., 2003, 51, 839-849.
31. Macedo, M.L.; de Sa, CM.; Freire, M.D.; Parra, J.R. A Kunitztype inhibitor of coleopteran proteases, isolated from Adenanthera pavonina L. seeds and its effect on Callosobruchus maculates. J. Agric. Food Chem., 2004, 52, 2533-2540.
32. Ng, T.B.; Lam, S.K.; Fong, W.P. A homodimeric sporamin-type trypsin inhibitor with antiproliferative, HIV reverse transcriptase-inhibitory and antifungal activities from wampee (Clausena lan-sium) seeds. Biol. Chem., 2003, 384, 289-293.
33. Kennedy, A.R. The evidence for soybean products as cancer preventive agents. J. Nutr., 1995, 125, 733S-7743S.
34. Kennedy, A.R.; Billings, P.C.; Maki, P.A.: Newberne, P. Effects of various preparations of dietary protease inhibitors on oral carcinogenesis in hamsters induced by DMBA. Nutr. Cancer, 1993, 19, 191-200.
35. Banerji, A.P. ; Fernandes, A.O. Field bean protease inhibitor preparations, unlike methotrexate, can completely suppress Yoshida sarcoma tumor in rats. Cell Biol. Int., 1994, 18, 1025-1034.
36. Banerji, A.; Fernandes, A.; Bane, S. Treatment with field bean protease inhibitor can effectively repress ethylnitrosourea (ENU)-induced neoplasms of the nervous system in Sprague-Dawley rats. Cancer Lett., 1998, 130, 161-167.
37. Banerji, A.; Fernandes, A.; Bane, S.; Ahire, S. The field bean protease inhibitor has the potential to suppress B16F10 melanoma cell lung metastasis in mice. Cancer Lett., 1998, 129, 15-20.
38. Troncoso, M.; Cerda Zolezzi, P.; Hellman, U.C. A novel trypsin inhibitor from Peltophorum dubium seeds, with lectin-like properties, triggers rat lymphoma cell apoptosis. Arch. Biochem. Biophys., 2003, 411, 93-104.
39. Fernandes, A.O.; Banerji, A.P. Inhibition of benzopyrene-induced forestomach tumors by field bean protease inhibitor(s). Carcinogenesis, 1995, 16, 1843-1846.
40. Fernandes, A.O.; Banerji, A.P. The field bean protease inhibitor can effectively suppress 7, 12-dimethylbenz[a]anthracene-induced skin tumorigenesis in mice. Cancer Lett., 1996, 104, 219-224.
41. Kobayashi, H.; Suzuki, M.; Kanayama, N.; Terao, T. A soybean Kunitz trypsin inhibitor suppresses ovarian cancer cell invasion by blocking urokinase upregulation. Clin. Exp. Metast., 2004, 21, 159-166.
42. von Hofe, E.; Newberne, P.M.; Kennedy, A.R. Inhibition of N-nitrosomethylbenzylamine-induced esophageal neoplasms by the Bowman-Birk protease inhibitor. Carcinogenesis. 1991, 12, 2147-2150.
43. Bell, H.A.; Fitches, E.C.; Down, R.E.; Ford, L.; Marris, G.C.; Edwards, J.P.; Gatehouse, I.A.; Gatehouse, A.M. Effect of dietary cowpea trypsin inhibitor (CpTI) on the growth and development of the tomato moth Lacanobia oleracea (Lepidoptera: Noctuidae) and on the success of the gregarious ectoparasitoid Eulophus pennicornis (Hymenoptera: Eulophidae). Pest Manage. Sci., 2001, 57, 57-65.
44. Giri, A.P.; Harsulkar, A.M.; Ku, M.S.; Gupta, V.S.; Deshpande, V.V.; Ranjekar, P.K.; Franceschi, V.R. Identification of potent inhibitors of Helicoverpa armigera gut proteinases from winged bean seeds. PhytoChem., 2003, 63, 523-532.
45. Lanza, A.; Tava, A.; Catalano, M.; Ragona, L.; Singuaroli, I.; della Cuna, R.; della Cuna, G.R. Effects of the Medicago scutellata trypsin inhibitor (MsTI) on cisplatin-induced cytotoxicity in human breast and cervical cancer cells. Anticancer Res., 2004, 24, 227-233.
46. Zhao, M.; Naude, R.I.; Muramoto, K.; Oelofsen, W. Purification and characterization of ostrich pancreatic secretory trypsin inhibitor. Int. J. Pept. Protein Res., 1996, 48, 174-181.
47. Zheng, H.; Wei, D. Q.; Zhang, R.; Wang, C.; Wei, H.; Chou, K. C. Screening for new agonists against Alzheimer's disease. Med. Chem., 2007, 3(5), 488-93.
48. Wei, H.; Zhang, R.; Wang, C.; Zheng, H.; Chou, K. C.; Wei, D. Q. Molecular insights of SAH enzyme catalysis and their implication for inhibitor design. J. Theor. Biol., 2007, 244, 692-702.
49. Gao, W. N.; Wei, D. Q.; Li, Y., Gao, H.; Xu, W. R.; Li, A. X.; Chou, K. C. Agaritine and its derivatives are potential inhibitors against HIV proteases. Med. Chem., 2007, 3, 221-226.
50. Zhao, K.; Li, A. X.; Wei, D. Q.; Chou, K. C. Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy. Amino Acids, 2007, 33,129-135.
51. Singh, S.S.; Rao, S.L. A monomeric protein with hemagglutinating activity from seeds of Vigna mungo (Phaseolus mungo). Indian J. Biochem. Biophys., 1991, 28, 439-443.
52. Okamoto, T.; Toyooka, K.; Minamikawa, T. Identification of a membrane-associated cysteine protease with possible dual roles in the endoplasmic reticulum and protein storage vacuole, J. Biol. Chem., 2001, 276, 742-751.
53. Wong, R.C.; Fong, W.P.; Ng, T.B. Multiple trypsin inhibitors from Momordica cochinchinensis seeds. Chinese Drug Mubiezhi, Pept., 2004, 25, 163-169.
54. Tsoi, A.Y.; Ng, T.B.; Fong, W.P. Immunomodulatory activity of a chymotrypsin inhibitor from Momordica cochinchinensis seeds. J. Pept. Sci., 2006, 12, 605-611.
55. Azarkan, M.; Dibiani, R.; Goormaghtigh, E.; Raussens, V.; Baeyens, V.D. The papaya Kunitz-type trypsin inhibitor is a highly stable beta-sheet glycoprotein. Biochem. Biophys. Acta, 2006, 1764, 1063-1072.
56. Nielsen, T.B.; Reynolds, I.A. Measurements of molecular weights by gel electrophoresis. Methods Enzymol, 1978, 48, 3-10.
57. Wong, I.H.; Ng, T.B. Sesquin, a potent defensin-like antifungal peotide from beans with inhibitory activities toward tumor cells and HIV-1 reverse transcriptase. Peptides, 2005, 26, 1120-1126.
58. Deshimaru, M.; Hanamoto, R.; Kusano, C.; Yoshimi, S.; Terada, S. Purification and characterization of proteinase inhibitors from wild soja (Glycine soja) seeds. Biosci. Biotechnol. Biochem., 2002, 66, 1897-1903.
59. Ye, X.Y.; Ng, T.B.; Rao, P.F. A Bowman-Birk-type trypsin-chymotrypsin inhibitor from broad beans. Biochem. Biophys. Res. Commun., 2001, 289, 91-96.
60. Althaus, I. W.; Chou, J. J.; Gonzales, A. I.; Diebel, M. R.; Chou, K. C.; Kezdy, F. I.; Romero, D. L.; Aristoff, P. A.; Tarpley, W. G.; Reusser, F. Steady-state kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-87201E. J. Biol. Chem., 1993, 268, 6119-6124.
61. Althaus, I. W.; Gonzales, A. I.; Chou, J. J.; Diebel, M. R.; Chou, K. C.; Kezdy, F. I.; Romero, D. L.; Aristoff, P. A., Tarpley, W. G., Reusser, F. The quinoline U-78036 is a potent inhibitor of HIV-1 reverse transcriptase. J. Biol. Chem., 1993, 268, 14875-14880.
62. Althaus, I. W.; Chou, J. J., Gonzales, A. I.; Diebel, M. R.; Chou, K. C.; Kezdy, F. I.; Romero, D. L.; Aristoff, P. A.; Tarpley, W. G.; Reusser, F. Kinetic studies with the nonnucleoside HIV-1 reverse transcriptase inhibitor U-88204E. BioChem., 1993, 32, 6548-6554.
63. Althaus, I. W.; Chou, J. J.; Gonzales, A. I.; Diebel, M. R.; Chou, K. C.; Kezdy, F. I.; Romero, D. L.; Aristoff, P. A.; Tarpley, W. G.; Reusser, F. Steady-state kinetic studies with the polysulfonate U-9843, an HIV reverse transcriptase inhibitor. Experientia, 1994, 50, 23-28.
64. Althaus, I. W.; Chou, J. J.; Gonzales, A. I.; Diebel, M. R.; Chou, K. C.; Kezdy, F. I.; Romero, D. L.; Thomas, R. C.; Aristoff, P. A.; Tarpley, W. G.; Reusser, F. Kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-90152E. Biochem. Pharmacol, 1994, 47, 2017-2028.
65. Althaus, I. W.; Chou, K. C.; Franks, K. M.; Diebel, M. R.; Kezdy, F. I.; Romero, D. L.; Thomas, R. C.; Aristoff, P. A.; Tarpley, W. G.; Reusser, F. (). The benzylthio-pyrididine U-31, 355 is a potent inhibitor of HIV-1 reverse transcriptase. Biochem. Pharmacol., 1996, 51, 743-750.
66. Chou, K. C.; Kezdy, F. I.; Reusser, F. Review: Steady-state inhibition kinetics of processive nucleic acid polymerases and nucleases. Anal BioChem., 1994, 221, 217-230.
67. Debouck, C. The HIV-1 protease as a therapeutic target for AIDS. AIDS Res. Hum. Retroviruses, 1992, 8, 153-164.
68. Chou, I. I. Predicting cleavability of peptide sequences by HIV protease via correlation-angle approach. J. Protein Chem., 1993, 72, 291-302.
69. Chou, J. J. A formulation for correlating properties of peptides and its application to predicting human immunodeficiency virus prote-ase-cleavable sites in proteins Biopolymers, 1993, 33, 1405-1414.
70. Anand, K.; Ziebuhr, I.; Wadhwani, P.; Mesters, I. R.; Hilgenfeld, R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science, 2003, 300, 1763-1767.